Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
2.5 ^USD	-0.79%		-13.49%	0.00%

04-25	Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip	CI
04-16	Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series	05-14	AQ
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip	04-25	AQ
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar	04-24	AQ
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech	04-16	AQ
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain	04-16	AQ
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology	04-15	AQ
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation	04-09	AQ
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker	04-08	AQ
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference	03-27	AQ
Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024	03-20	AQ
Autonomix Appoints Jennifer Cook as Chief Business Officer	03-19	AQ
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	03-14	AQ
Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	03-06	AQ
Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial	02-29	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity	02-23	AQ
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study	02-22	AQ
Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market	02-16	AQ
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones	02-14	AQ
Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain	02-06	AQ
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event	02-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Press Releases

Filters